UK up­start rais­es $100M in bid to dig­i­tize and stan­dard­ize cell and gene ther­a­py man­u­fac­tur­ing

There’s a gi­ant need for cell and gene ther­a­py man­u­fac­tur­ing op­tions go­ing for­ward, as com­pa­nies move to in­vest mas­sive­ly in­to that space. Ori Biotech is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER